At the fibrosis-dominant end of the spectrum, systemic sclerosis itself and systemic sclerosis-ILD exhibit constitutive fibroblast activation and TGF-β-driven extracellular matrix production early in the disease course. This evidence concerns the gene TGFB1 and interstitial lung disease.